Garlic supplementation may improve glycemic markers but has no effect on androgens in PCOS Niveditha Subramani23 Oct 2023 8:00 PM IST"Polycystic Ovarian Syndrome (PCOS) a concerning public health problem and is one of the commonest hormonal disturbances affecting women of...
Insulin resistance CV risk factor in hypertensive adults without type 2 diabetes Dr. Shravani Dali23 Oct 2023 8:00 PM ISTInsulin resistance a CV risk factor in hypertensive adults without type 2 diabetes suggests a new study published in the Wien Klin...
Use of sugar in coffee, tea may not increase risk of incident diabetes or mortality Medha Baranwal23 Oct 2023 11:30 AM ISTDenmark: The use of sugar in coffee and/or tea was not significantly associated with increased risk of mortality or incident diabetes, a recent study...
Low serum desnutrin predicts insulin resistance in patients with vitiligo vulgaris Medha Baranwal23 Oct 2023 10:15 AM ISTEgypt: Low serum desnutrin could be a biomarker for insulin resistance in vitiligo vulgaris patients, says a recent study published in the Indian...
Study endorses use of closed-loop in type 1 diabetes associated with Pregnancy Dr. Kamal Kant Kohli23 Oct 2023 9:30 AM ISTA new study endorses closed-loop use in type 1 diabetes pregnancy and highlights how the technology can facilitate positive pregnancy experiences. The...
Red meat intake tied to increased risk of type 2 diabetes Dr. Kamal Kant Kohli21 Oct 2023 11:30 AM ISTUSA: Findings from a new study published in The American Journal of Clinical Nutrition support current dietary recommendations for limiting red meat...
Dapagliflozin or saxagliptin, which is better for children with type 2 diabetes? Medha Baranwal21 Oct 2023 11:15 AM ISTUSA: A phase III T2NOW trial comparing dapagliflozin or saxagliptin in pediatric type 2 diabetes revealed that Dapagliflozin (Farxiga) lowered HbA1c...
Teplizumab Shows Promise in Preserving Beta-Cells in Early Type 1 Diabetes: PROTECT Trial Results Dr Riya Dave21 Oct 2023 10:00 AM ISTIn a recent study, researchers have found that early administration of teplizumab, marketed as Tzield, may help preserve beta-cells in individuals...
Even low doses of radiation may contribute to diabetes shows Study from Fukushima Dr. Kamal Kant Kohli20 Oct 2023 8:00 PM ISTNew research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Hamburg (2-6 Oct), suggests...
Fotagliptin, potential new approach for treatment-naive patients with type 2 diabetes Medha Baranwal20 Oct 2023 11:30 AM ISTChina: A recent study published in BMC Medicine revealed Fotagliptin, a novel DPP4 inhibitor, to be noninferior to alogliptin and significantly more...
Rosuvastin bests atorvastatin for cholesterol lowering with more risk of developing diabetes: BMJ Dr. Kamal Kant Kohli20 Oct 2023 11:15 AM ISTKorea: A secondary analysis of the randomised LODESTAR trial evaluated the rosuvastatin versus atorvastatin treatment in adults with coronary artery...
Commonly prescribed statin increases risk of type 2 diabetes, finds BMJ study Isra Zaman20 Oct 2023 9:15 AM ISTTwo widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary...
